Clearside Biomedical Enters into Strategic Collaboration with EyeKor to Support Clinical Development Efforts
ALPHARETTA, Ga. and MADISON, Wis., March 31, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical Inc. (Nasdaq:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, announced today that it has …